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Abstract The modulation by protein kinase C (PKC) of the 
RCKI K ÷ channel was investigated in Xenopus oocytes by 
integration of two-electrode voltage clamp, site-directed muta- 
genesis and SDS-PAGE analysis techniques. Upon application of 
~-phorbol 12-myristate 13-acetate (PMA) the current was 
inhibited by 50-90%. No changes in the voltage sensitivity of 
the channel, changes in membrane surface area or selective 
elimination of RCKI protein from the plasma membrane could 
be detected. The inhibition was mimicked by l-oleoyl-2-acetyl- 
rac-glycerol (OAG) but not by c~PMA, and was blocked by 
staurosporine and calphostin C. Upon deletion of most of the N- 
terminus a preceding enhancement of about 40% of the current 
was prominent in response to PKC activation. Its physiological 
significance is discussed. The N-terminus deletion eliminated 
50% of the inhibition. However, phosphorylation of none of the 
ten classical PKC phosphorylation sites on the channel molecule 
could account, by itself or in combination with others, for the 
inhibition. Thus, our results show that PKC activation can 
modulate the channel conductance in a bimodal fashion. The N- 
terminus is involved in the inhibition, however, not via its direct 
phosphorylation. 
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tion of channels by integrating electrophysiological nalysi 
with molecular biology techniques. Thus, it was shown that 
the function of a slowly activating K + channel (minK) is 
modulated by PKC activation through phosphorylation of a 
serine residue on the channel molecule [5] and by PKA acti- 
vation, but not through direct channel phosphorylation [6,7]. 
The Shaker D, Shaker B [8] and Kvl .2  [9] channels were 
shown to be modulated by PKA activation via phosphoryla- 
tion of a specific serine residue in each molecule and the 
hKv3.4 channel was shown to be modulated by PKC phos- 
phorylation of two serine residues [10]. 
Recently, with the addition of a biochemical approach to 
the study of K + channels in oocytes, we could show that the 
rat brain RCK1 channel (Kvl .1;  ref. [11]), that functions in 
oocytes as a delayed rectifier-type of K + channel [12], is 
modulated by PKA activation through two separate mechan- 
isms, one via direct channel phosphorylation at Ser-446 on the 
C-terminus and the other involving enhanced synthesis of the 
channel protein [13,14]. In the present work we have extended 
the study of this channel and characterize its modulation by 
PKC activation. We also show that, in contrast to the PKA 
modulation, the N-terminus is probably involved in the PKC 
modulation and not through direct channel phosphorylation. 
1. Introduction 
Voltage-gated K + channels are a diverse group of ion chan- 
nels present in most eukaryotic cells. A major function of 
these channels is to set the membrane potential and hence 
regulate the electrical excitability of the cell [1]. 
Regulation of channel function by protein phosphorylation 
has been described for a number of different classes of K + 
channels in their native cellular environment [2]. The use of 
Xenopus oocytes enhanced understanding of the regulation by 
phosphorylation of K + channels expressed from a single spe- 
cies of cRNA. Thus, for example, we were able to show that 
the A-type channels expressed from either chick brain RNA 
[3] or Shaker H4 cRNA [4] are modulated by PKC activation. 
Moreover, the use of Xenopus oocytes allows correlation of 
protein kinase-mediated modulation with direct phosphoryla- 
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2. Materials and methods 
2.1. Site-directed mutagenesis 
All mutations were performed on the expression vector SupEx- 
RCK1, which confers high levels of expression [13]. Oligonucleotide- 
mediated mutagenesis was performed using the Amersham mutagen- 
esis kit, essentially as described [13], using single-stranded DNA as 
templates and oligonucleotide primers (synthesized by General Bio- 
technology Inc., Rehovot) encoding the desired mutations. Subse- 
quent mutations were prepared using a template derived from the 
wild type (WT) DNA and the following primers (bold nucleotides 
encode the mutated residues): $322C, 5' CCTCAAAGCTTGTAT- 
GAGGGA 3' ;R324M, 5' GCTAGTATGATGGAGTTAGGG 
3';$489I, 5' GTTAATAAGATCAAGCTCCTG 3';R443C;S446A, 
5' GTGACCTCAGCTGCCGCAGCGCCTCTACTATCAGC 
3';$23I, 5' CAGGATGGCATCTACCCAAGG 3';R47G;K53Q, 5' 
CTCCGGGCTGGGCTTCGAGACGCAGCTCCAGACTCTGGC 
3';$88I, 5' AACCGGCCCATCTTCGATGCC 3';$98A, 5' TTAC- 
TACCAGGCGGGGGGGCG 3'. 
The mutations $332C;$489I and S322C;R47G;K53Q were pre- 
pared using the template derived from $322C DNA and the appro- 
priate primers (see above). The mutation S322C;R47G;K53Q;S98A 
was prepared using S322C;R47G;K53Q as a template and the appro- 
priate primer. The del-N construct was prepared by digestion of the 
SupEx-RCK1 with NcoI (deletion of the first 126 amino acids from 
the N terminus). The construct del-N with $322C;$489I was prepared 
by digestion of $332C;$489A with NcoI. All mutations cDNAs were 
linearized by NotI and the corresponding cRNAs synthesized by T7 
RNA polymerase. 
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2.2. Oocytes, electrophysiological recording, drug application and 
statistics 
Frogs were maintained and dissected and oocytes were prepared as 
described [13]. The oocytes were injected with about 0.2 ng cRNA and 
incubated at 22°C for 3 6 days in ND96 solution (96 mM NaC1, 2 mM 
KCI, 1 mM MgC12, 5 mM Hepes, pH 7,5) supplemented with 1.8 mM 
CaC12, 2.5 mM sodium pyruvate, 100 p.g/ml streptomycin and 100 U/ 
ml penicillin (NDE solution), and then assayed electrophysiologically. 
An oocyte was placed in a 1 ml bath constantly perfused with the 
ND96 solution supplemented with 1 mM CaCI2. Currents were re- 
corded using a Dagan 8500 two-electrode voltage clamp amplifier 
with a series resistance compensation circuit and low resistance 
(0.2-0.5 MD) electrodes [14]. Data acquisition and analysis were 
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done by the pCLAMP software (Axon Instruments, Foster City, 
CA, USA; ref. [14]). The holding potential was set to -80  mV and 
the potential was then stepped to 0 mV for 150 to 400 ms. The net 
current was estimated by arithmetical subtraction of the scaled leak 
current calculated from the current elicited by a voltage step to -90  
mV. When current/voltage r lationship was studied, the holding po- 
tential was set at -80  mV and stepped to -100  mV for 50 ms (pre- 
pulse), before depolarizing the membrane potential to different vol- 
tages for 150 ms. The net current was estimated by subtraction of the 
leak current that was the average value of scaled currents elicited by 
voltage steps to -80  and -70  inV. The capacitance of the oocyte 
membrane was measured as the area under the capacitive current 
elicited by a step from -80  to -70  mV. After stability of the current 
< 
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Fig. I. Modulation of IRCK1 by PKC activation. A: Currents elicited by voltage steps from a holding potential of -80  mV to 0 mV before 
(control) and 25 min after PMA application. B: Steady-state activation curves of IRCK] before (circles, n=9)  and 20 min after (squares, n=6)  
application of 10 nM PMA. A 50 ms prepulse to -100  mV was applied, followed by a test pulses to various voltages (--80 to +20 mV) in 10 
mV increments, every 4 s (at +20 mV maximal conductance was observed). C: Time scale of the effects on IRCK1 of 10 nM PMA (circles, 
n = 15), 10 mM OAG (downward triangles, n = 5) and 100 mM 0tPMA (upward triangles, n = 5). Squares represent the effect of 10 nM PMA 
on capacitance (n=7;  see section 2). D: Effects of PKC inhibitors. The effects of PMA on IRCK] in oocytes (filled symbols) that were pre- 
viously exposed for 0.5-2 h to 3 laM staurosporine (left panel, n = 6), for 1 6 h to 5 IIM calphostin C (middle panel, n=3), and for 1-6 h to 
both inhibitors (right panel, n = 3). Untreated oocytes are represented by open symbols (n =4; 3; 3, respectively). In C and D, the currents 
were elicited by 400 ms voltage steps from -80  mV to 0 mV. Shown are the mean normalized current amplitudes with error bars that represent 
S.E.M. In all cases net currents are shown (see section 2). 
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amplitude had been verified for at least 5 min (usually up to 15 min), 
!3-phorbol 12-myristate 13-acetate ([~PMA), aPMA, and diacylglycer- 
ol 1-oleyl-2-acetyl-rac-glycerol (OAG) were applied by bath perfusion. 
Inhibition by staurosporine was assessed in oocytes incubated in 3 gM 
solution for 0.5 to 2 h, prior to drug application. Inhibition by cap 
phostin C was assessed in oocytes incubated in 5 gM solution for 1 to 
6 h (illuminated under standard fluorescent light). The results in the 
text are presented as means + S.E.M. Two-tailed t-test was used to 
calculate the statistical significance of the differences between two 
populations. 
2.3. Immunoprecipitation 
Labeling of oocytes, plasma membranes preparation, homogeniza- 
tion and immunoprecipitation were done as described [13,14]. Quan- 
tification of labeling intensities and generation of digitized Phosphor- 
Imager (Molecular Dynamics) scans were done essentially as 
described [14]. 
2.4. Materials 
All substances were purchased from Sigma except ctPMA (LC- 
Services; Woburn, MA) and OAG (Calbiochem). ctPMA, [3PMA, 
OAG and staurosporine were dissolved at 10 mM in DMSO and 
kept at -20°C. PMA and OAG were light protected, OAG was 
also stored under nitrogen. Final concentrations were made up in 
ND96 solution just before use. 
3. Results 
3.1. Modulation of the full-length RCK1 channel 
About 3 to 6 days after injection of cRNA coding for the 
RCK1 rat brain voltage-gated K + channel into Xenopus oo- 
cytes, the K ÷ current (IrtcKa) was recorded using the two- 
electrode voltage clamp technique. As reported previously 
[12], the current was of a delayed-rectifier-type (Fig. 1A). 
The modulation of IRCK1 by PKC was examined first by con- 
stant bath perfusion with the PKC activator, PMA. Within 5 
to 10 min the current amplitude started to decline and by 20 
min had reached about 27% of its original value (P<0.001; 
A B 
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Fig. 2. PMA treatment does not affect the amount of RCK1 protein 
in plasma membranes (A) and in whole oocytes (B). Shown are di- 
gitized Phosphorlmager scans of SDS-PAGE analysis of [aSS]met/ 
cys-labeled RCK1 protein products immunopurified from either 17 
plasma membranes or five whole oocytes after incubation for 
20 min in the presence and absence of 100 nM PMA (as indicated). 
The scans in A and B were derived after 5 and 1 days of exposure, 
respectively. Thin arrows denote molecular weight markers in kDa. 
Fig. 1A,C). Three types of control experiments were carried 
out to verify that the effect of PMA was indeed due to its 
activation of PKC:  (i) ctPMA (10 nM), an isomer that is 
inactive with respect to PKC, had practically no effect (Fig. 
1C). (ii) The synthetic diacylglycerol OAG (10 gM), another 
activator of PKC, reduced IRCK1 amplitude to 40% of its 
original value after 40 min (P<0.001; Fig. 1C). (iii) Two 
protein kinase inhibitors, staurosporine and calphostin C 
[15,16] attenuated the effect of PMA (Fig. 1D). To overcome 
possible variability in the PMA effect among different donors, 
we compared in the same donor the effects of PMA in the 
presence and absence of the inhibitors. Thus, the effects of 
PMA were weakened by staurosporine and by calphostin C 
by about 60% (P<0.001) and 85% (P<0.001), respectively. 
Simultaneous application of the two inhibitors (calphostin C 
interacts with the regulatory domain of PKC while stauro- 
sporine interacts with the catalytic domain) weakened the ef- 
fect of PMA by 87% (P< 0.00). Staurosporine alone had prac- 
tically no effect as it decreased IRCK1 amplitude to 96.2 + 2.8% 
(n = 5) of control after 20 min. 
To assess the effect of PMA on the voltage sensitivity of the 
channel steady-state activation curves of currents before and 
during PMA application were compared. Groups of currents 
evoked by depolarizing steps to various voltages before and 
20 min after PMA application were recorded. Conductances 
(G) at all voltages were calculated and normalized to peak 
conductance at +20 mV (Gm~) and steady-state activation 
curves were derived (Fig. 1B). The two curves practically over- 
lapped, indicating that the effect of PMA was not the result of 
a positive shift in the voltage dependency of activation. 
In order to exclude the possibility that the effect of PMA is 
to accelerate internalization of the channels rather than to 
affect the channel function, we carried out two sets of experi- 
ments. Monitoring the capacitance of the oocyte membrane 
during the PMA application revealed that it did not change 
significantly during the experiment (Fig. 1C), indicating that 
the decrease in IRCK1 was not due to a decrease in the mem- 
brane surface area. Furthermore, SDS-PAGE analysis of the 
immunopurified RCK1 protein (that is expressed in the oocyte 
in the form of a doublet; see refs. [13,14]) revealed that PMA 
treatment did not affect the amount of total or the plasma 
membrane protein content of the oocytes. Thus, the estimated 
ratios of the amount of protein in PMA treated (10 or 100 nM 
for 20 or 60 min) versus untreated oocytes were 1.1 _+ 0.1 and 
1.14+0.19 (15 and 4 experiments, respectively) for the total 
and plasma membrane proteins, respectively (see Fig. 2). It 
was therefore concluded that the PMA-induced decrease in 
/RCKI was not due to a reduction in the amount of plasma 
membrane RCK1 channels that were shown to represent func- 
tional channels [13]. 
3.2. Modulation of the N-terminus truncated channel 
Deletion of the first 126 amino acids from the N-terminus 
generated a functional channel (del-N); however, this channel 
required cRNA concentrations two orders of magnitude lar- 
ger than those in the full-length channel for expressing com- 
parable current amplitudes. The kinetics of the current 
through del-N (Idd N) were similar to those of IaCKi (compare 
Figs. 1A and 3B) and its voltage sensitivity did not seem to be 
altered (Fig. 3A). However, 10 nM PMA caused a biphasic 
response of IDd i with an early increase of current to about 
140% of the initial value (P< 0.003), which peaked after about 
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6 min, followed by a significant reduction of the current to 
about  30% of the initial value (P< 0.0005), within 25 min. The 
extent of reduction was about  50% of the corresponding re- 
duction in I I tCKa  in oocytes of the same donors (P<0.003;  
Fig. 3C). OAG (10 gM)  mimicked both  the enhancement 
(P<0.0025) and the suppression (P<0.0005) of the current 
amplitudes which were of comparable magnitude to those in- 
duced by PMA (tested in the same donors;  Fig. 3E). Both 
effects induced by PMA were significantly attenuated in the 
presence of 3 mM staurosporine (at 7 min P<0.05;  at 25 min 
P<0.001;  Fig. 3E). The steady-state activation behaviors of 
Idol N at 6 and 20 min after PMA application were practically 
unaffected (Fig. 3D), indicating that both the suppression and 
the initial enhancement of Idel-N occurred not because of al- 
tered voltage sensitivity but probably because of changes in 
the conductance. Also, the kinetics of Idd-N did not seem to 
be altered by PMA (Fig. 3B). 
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Fig. 3. Modulation of Idd N by PKC activation. A: Steady-state activation curves of IRCK1 (squares, n=4) and Idd-N (circles, n= 5). A 50 ms 
prepulse to --100 mV was applied, followed by test pulses to various voltages ( -80 to +20 mV) in 10 mV increments (at +20 mV maximal 
conductance was observed). B: Idei-N elicited by 150 ms pulses from a holding potential of -80 mV to 0 mV, before (control), 6 min after (6') 
and 25 min (25') after PMA application. C: Time scale of the effect of 10 nM PMA on IRCK1 (circles, n=8) and on Ide]-N (diamonds, n=9). 
Shown are mean normalized currents with error bars that represent S.E.M. D: Steady-state activation curve of Ide] N (n= 6) before (circles), 
6 min (squares) and 15 min (triangles) after PMA application. A 50 ms prepulse to -100 mV was applied, followed by test pulses to various 
voltages (--80 to +20 mV) in 10 mV increments. E: Time scale of the effects of 10 nM PMA (open circles, n = 11), 10 mM OAG (open trian- 
gles, n = 3) and 10 nM PMA after exposure for 0.5-2 h to 3 mM staurosporine (squares); note different Y axis scale. Shown are mean normal- 
ized currents with error bars that represent S.E.M. F: Enlargement of the figure showing the IRCK1 response to PMA in the first minutes after 
the drug application. Time course of the effects of vehicle wash (upward triangles), 1 nM PMA (downward triangles), 10 nM PMA (diamonds). 
The figure shows the mean normalized currents with error bars that represent S.E.M., where the augmentation is significantly different from 
the vehicle wash values; n = 5 for all treatments. 
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Idel-N, we carefully re-examined the effect of PMA on IRCK1. 
In oocytes of most of the donors tested we found an early 
tiny increase of the current amplitude that was reproducible 
and statistically significant at 10 nM PMA (4%; P<0.05; Fig. 
3F). 
3.3. The role of 'classical' consensus PKC sites in the 
PMA-induced effects 
Ten PKC phosphorylation sites, serine or threonine flanked 
by basic amino acids [17], were identified on the assumed 
intracellular parts of the RCK1 channel protein (see Fig. 4). 
Mutant cDNAs were generated in which one or more of these 
sites were truncated by replacement of either the serine, threo- 
nine or the basic amino acids with different amino acids (see 
section 2). Since the expression of currents is sometimes im- 
paired by mutations, we ensured their maximum expression 
by using a construct of the channel in a 'super-expressing' 
vector that confers high levels of expression in oocytes (see 
section 2). The corresponding cRNAs were injected into the 
oocytes and the responses to PMA of the currents through 
the resulting mutant channels were examined. None of the 
mutations affected significantly the responses of the currents 
to PMA. In an attempt o probe for synergistic interactions 
among several potentially phosphorylation sites, several si- 
multaneous mutations at different parts of one RCKI mole- 
cule were generated. Simultaneous mutations in the full 
length channel at Ser-322, Ser-44, Thr-49 Thr-54 and Ser- 
98, as well as simultaneous mutations at Ser-322 and Ser- 
489, did not affect the PMA-induced modulation of the cur- 
rent. Simulataneous mutations in the del-N construct at Ser- 
322 and Ser-489 resulted in a channel that did not express 
current. 
4. Discussion 
4.1. Bimodal effect of PKC activation 
In this study we show that RCK1 channel expressed in 
oocytes is modulated by PKC activation. The dominant effect 
appears to be a strong inhibition of 50% to 90% (depending 
on the donor). Examination of the mechanism underlying the 
inhibition revealed that it is not due to a shift of the voltage 
sensitivity to more positive potentials, nor does it result from 
non-specific nternalization f membrane proteins due to over- 
all reduction in membrane surface area. Moreover, by com- 
paring the amounts of RCK1 protein in the plasma mem- 
branes of treated and untreated oocytes, we present evidence 
that the inhibition is not due to a selective limination of K + 
channel proteins from the plasma membrane. We therefore 
conclude that the inhibition results from reduced RCK1 con- 
ductance. The nature of this reduced conductance, in particu- 
NH3* 
23 44 50 54 88 98 318 322 446 
coo- 
489 
Fig. 4. Scheme of the proposed transmembrane topology of the 
RCK1 protein (monomer). The PKC consensus phosphorylation 
sites that were truncated in this work are denoted by S (serine) and 
T (threonine). Serine 446 (in square) is the site of PKA phosphory- 
lation [13]. 
lar whether it is manifested in the intrinsic characteristics of
single channels or involves other mechanisms, e.g. recruitment 
of channels to non-functional pools (see also ref. [14]), re- 
mains to be determined. 
Interestingly, upon truncation of the N-terminus, an early- 
phase enhancement of the current amplitude of about 40% is 
observed. Like the inhibition, the enhancement is a result of 
PKC activation, and probably occurs via changes in the 
channel conductance. Such effects of a bimodal nature by 
PMA have been described for other voltage-gated ion chan- 
nels. We [18] and others [19] have described such effects for 
L-type Ca 2+ channels either expressed in Xenopus oocytes or 
derived from ventricular myocytes [20,21], and for the hu- 
man Kvl.1 K + channel expressed in Xenopus oocytes [22]. 
When concidering the mechanism underlying the bimodal 
nature of the PMA-induced effect on the truncated RCK1 
channel one possibility arises that the enhancement is a com- 
ponent of the full length channel modulation that is ob- 
scured by the overlapping inhibition and is revealed when 
50% of the inhibition is removed upon N-terminus deletion. 
In such a context he observed initial tiny enhancement of 
the current through the full-length channel represents the 
underlying enhancement. Another possibility is that the en- 
hancement is a novel phenomenon i troduced by the dele- 
tion of the N-terminus. This requires that the truncation 
renders new sites on the molecule responsive to PKC activa- 
tion, sites that are not available in the full-length channel 
because of an unfavorable t rtiary and/or quaternary confor- 
mation imposed by the N-terminus. Indeed it seems reason- 
able to assume that the structure of the Kvl.1 molecule is 
influenced by the N-terminus, which participates in the as- 
sembly and contributes to the stabilization of the multimeric 
channel [23]. Supportive data come from the study of Stock- 
er et al. [24] that demonstrated that two alternatively spliced 
Drosophila Shaker K + channels, differing only in their amino 
termini, exhibited profound differences in their sensitivities 
towards tetraethylammonium and charybdotoxin that inter- 
act with the pore region of the molecule. Also, Wilson et al. 
[25] have shown that the drkl K + current can be modulated 
by protein kinase A only upon deletion of the first 139 
amino acids of the N-terminus. 
The question arises whether the enhancement effect that 
becomes ignificant only after truncation of the N-terminus 
is of relevance to the physiological functioning of the full- 
length channel. Notably, two Kvl.4 homologs which are 
95.6% identical in their amino acid sequence do not respond 
similarly to PMA, when expressed in Xenopus oocytes. The rat 
homolog undergoes only suppression over time with no initial 
enhancement observed [26], whereas the human homolog re- 
sponds in a biphasic manner with an initial enhancement fol- 
lowed by suppression [22]. Most of the differences (76% mis- 
match) between these two molecules lie in the N terminus 
suggesting that alterations in the N-terminus may regulate 
the responses to intracellular signals, such as PKC activation. 
Interpretation of the RCK1 modulation data leads us to 
further speculate that such regulation of reponses to PKC 
activation may be achieved even with the same channel mo- 
lecule. One can assume that in the full-length channel engage- 
ment of the N-terminus by interactions with intracellular pro- 
tein(s) has the same consequences on the channel structure as 
N-terminus deletion, hence affecting the modulation of the 
channel by PKC activation. 
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4.2. The inhibitory effect is mediated partially by the 
N-termiaus, probably not via direct phosphorylation 
Upon removal of most of the N-terminus about 50°/,, of the 
inhibition induced by PKC activation was eliminated suggest- 
ing that this part of the molecule is responsible for a signifi- 
cant portion of the inhibitory effect. The question arised 
whether this part of the inhibition, as well as the rest of the 
inhibition, are mediated via direct phopshorylation of serine 
or threonine residues on the channel molecule. Several mem- 
brane proteins have been shown to be modulated by PKC 
activation via direct protein phosphorylation. These include 
the rat kidney minK [5] and the human hKv3.4 [10] K + chan- 
nels, the Na + channel [27,28] the GABAA receptor [29,30], 
and the Na,K-ATPase a subunit [31]. We found that this is 
probably not the case with the RCK1 channel as phosphor- 
ylation of none of the classical potential PKC phosphoryla- 
tion sites [17] on the RCK1 protein (six of which reside in the 
N-terminus) could account for the inhibitory effect by the 
PKC activation. Also, no synergistic effect among the phos- 
phorylation sites such as had been observed in the case of 
CFTR [32] and the Na + channels [33] could be detected. 
Nevertheless, PKC-recognition sequences are diverse, and a 
broad range of substrate specificity has been reported [34]. 
Also, a novel motif  for PKC-mediated phosphorylation was 
recently identified for the Na,K-ATPase molecule which is not 
contained within a conventional consensus equence for PKC 
[31]. Therefore, we can not rule out completely the possibility 
that the inhibitory effect by PKC could be conveyed through 
direct channel phosphorylation of sites not yet identified. The 
possible involvement of tyrosine phopshorylation i this mod- 
ulation has been also considered in view of the recent data 
describing the modulation of a related voltage-gated K + chan- 
nel [36,37]. This possibility, however, does not seem to us 
plausible as a tyrosine kinase inhibitor (genistein) did not 
affect the modulation by PKC (data not shown). 
Activation of PKC has been implicated in plasticity phe- 
nomena in the brain, such as long-term potentiation, although 
the underlying mechanisms are not fully understood (for re- 
view see ref. [35]). One of such mechanisms may be a long- 
lasting inhibition by PKC of a voltage-dependent K ÷ channel, 
such as described in this report, which may be expected to 
cause a prolonged increase in nerve cell excitability. 
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